|
Myelosuppressive therapies are used to slow down the body's production of blood cells. They are given to patients who are older than 60 and at high risk for thrombosis. These therapies, however, increase the patient's risk of developing leukemia. ...
|
|
Anagrelide lowers the number of blood clotting cells (called platelets) in the body. This
helps to prevent blood clots from forming.
|
|
Anagrelide, also known by the brand name Agrylin, is used to treat patients with thrombocytosis, a condition in which patients have too many platelet cells in their blood. Platelets are a cell type formed in the bone marrow that are involved in the blood clotting process.
|
|
Hydroxyurea affects certain cells in the body, such as cancer cells or sickled red blood
cells.
|
|
Hydroxyurea, also known by its trade name Hydrea, is an antineoplastic agent, meaning it is used to treat cancer. It is taken orally.
|
|
Interferon alfa-2b is made from human proteins. Interferons help the body fight viral
infections.
|